Search results

Filter

Filetype

Your search for "*" yielded 558583 hits

Optimal blood tests for development of new therapies of Alzheimer’s disease

A new study have identified which blood tests are best at detecting Alzheimer’s disease during the earliest stages, and also another blood test that is optimal for detecting relevant treatment effects. These findings will speed up the development of new therapies that can slow down the disease progression. The article was originally published as a press release from the Sahlgrenska Academy, Univer

https://www.multipark.lu.se/article/optimal-blood-tests-development-new-therapies-alzheimers-disease - 2026-05-17

Nobel Prize winner Arvid Carlsson – 7 things you perhaps did not know about him and his research

“Lundensare” Nobel Prize winner Arvid Carlsson (1923-2018) did not receive the prestigious Nobel Prize while living or working in Lund – but he is an alumnus! Carlsson grew up in Lund (which could clearly be heard in his Lund accent) and in 1951 he became a doctor of medicine at Lund University. He was employed as an associate professor of pharmacology and in 1959 he left for Gothenburg, where he

https://www.multipark.lu.se/article/nobel-prize-winner-arvid-carlsson-7-things-you-perhaps-did-not-know-about-him-and-his-research - 2026-05-17

Molecular signaling in neurodegenerative disorders – A special interest group

MultiPark’s new special interest groups (SIGs) address essential scientific and technological needs and provide opportunities for professional development and network formation to our young scientists. One of them focus on molecular signaling. Lautaro Belfiori is the convening person. He shares with us how they plan to work with questions related to molecular signaling. Can you shortly describe th

https://www.multipark.lu.se/article/molecular-signaling-neurodegenerative-disorders-special-interest-group - 2026-05-17

Cognitive disease beyond the brain – PhD interview with Keivan Javanshiri

Keivan Javanshiri’s Ph.D. project explores cardiac and vascular pathologies in Lewy body dementia and Alzheimer's disease. January 20, he defends his thesis. Here, he shares the most important findings and why sudden cardiac arrest is a common cause of death in patients with Lewy body disease. Tell us about your research! “My research focuses on cognitive disorders, which you may envision like a t

https://www.multipark.lu.se/article/cognitive-disease-beyond-brain-phd-interview-keivan-javanshiri - 2026-05-17

MultiPark – Closing the circle of 2022 and looking forward to 2023

We ended the MultiPark year in December as we started it in January: with a MultiPark Retreat! The December retreat was our first big meeting IRL after the pandemic, and it turned out to be a much appreciated event. Thank you to all participants, and thank you once again to the retreat organizing committee for doing such a great job! 2022 was a year of “reopening”. Like a butterfly spreads its win

https://www.multipark.lu.se/article/multipark-closing-circle-2022-and-looking-forward-2023 - 2026-05-17

High-tech method for uniquely targeted gene therapy developed

This article is over 5 years old, and the information may therefore be outdated. Neuroscientists at Lund University in Sweden have developed a new technology that engineers the shell of a virus to deliver gene therapy to the exact cell type in the body that needs to be treated. The researchers believe that the new technology can be likened to dramatically accelerating evolution from millions of ye

https://www.multipark.lu.se/article/high-tech-method-uniquely-targeted-gene-therapy-developed - 2026-05-17

Blood test enables early diagnosis of Alzheimer's disease

This article is over 5 years old, and the information may therefore be outdated. Diagnosing Alzheimer's disease is often difficult, as several other conditions can cause similar symptoms. Researchers at Lund University in Sweden have now discovered a blood marker that can accurately diagnose Alzheimer’s in the early stages of the disease.Read the full article here

https://www.multipark.lu.se/article/blood-test-enables-early-diagnosis-alzheimers-disease - 2026-05-17

New imaging method sheds light on Alzheimer's disease

This article is over 5 years old, and the information may therefore be outdated. To understand what happens in the brain when Alzheimer's disease develops, researchers need to be able to study the molecular structures in the neurons affected by Alzheimer's disease. Researchers at Lund University in Sweden have tested a new imaging method for this purpose. The research is published in the journal A

https://www.multipark.lu.se/article/new-imaging-method-sheds-light-alzheimers-disease - 2026-05-17

New method provides unique insight into the development of the human brain

This article is over 5 years old, and the information may therefore be outdated. Stem cell researchers at Lund University in Sweden have developed a new research model of the early embryonic brain. The aim of the model is to study the very earliest stages of brain to understand how different regions in the brain are formed during embryonic development. With this new insight, researchers hope to be

https://www.multipark.lu.se/article/new-method-provides-unique-insight-development-human-brain - 2026-05-17

How toxic protein spreads in Alzheimer’s disease

This article is over 5 years old, and the information may therefore be outdated. Toxic versions of the protein tau are believed to cause death of neurons of the brain in Alzheimer’s disease. A new study published in Nature Communications shows that the spread of toxic tau in the human brain in elderly individuals may occur via connected neurons. The researchers could see that beta-amyloid facilita

https://www.multipark.lu.se/article/how-toxic-protein-spreads-alzheimers-disease - 2026-05-17

Message from the coordinator

This article is over 5 years old, and the information may therefore be outdated. From the coordinator:As we approach Midsommar, we in MultiPark can reflect on the extraordinary last few months and hope that our environment can return back more to meetings, seminars and productive exchanges after the summer. Although neurodegenerative diseases were less in the news because of Covid-19, people with

https://www.multipark.lu.se/article/message-coordinator - 2026-05-17

New research paves way for developing therapies that could slow down Alzheimer´s

This article is over 5 years old, and the information may therefore be outdated. Neuroscientists and stem cell researchers at Lund University in Sweden have developed a research model that allows studying human hippocampal neurons, the brain cells primarily affected by Alzheimer’s disease pathology. The study has been published in Stem Cell Reports.Read the full article here.See also interview wit

https://www.multipark.lu.se/article/new-research-paves-way-developing-therapies-could-slow-down-alzheimers - 2026-05-17

New blood test shows great promise in the diagnosis of Alzheimer’s disease

This article is over 5 years old, and the information may therefore be outdated. A new blood test demonstrated remarkable promise in discriminating between persons with and without Alzheimer’s disease and in persons at known genetic risk may be able to detect the disease as early as 20 years before the onset of cognitive impairment, according to a large international study published today in the J

https://www.multipark.lu.se/article/new-blood-test-shows-great-promise-diagnosis-alzheimers-disease - 2026-05-17

Millions from Michael J. Fox Foundation to improve diagnosis of Parkinson's

This article is over 5 years old, and the information may therefore be outdated. Around 20,000 people have been diagnosed with Parkinson's disease in Sweden. Today, there is no imaging method of changes in the brain that are believed to cause the disease. Researchers at Skåne University Hospital and Lund University have received nearly SEK 7 million from the Michael J Fox Foundation to develop an

https://www.multipark.lu.se/article/millions-michael-j-fox-foundation-improve-diagnosis-parkinsons - 2026-05-17

Of Four Aβ Antibodies, Only Aducanumab Stems Tide of Toxic Oligomers

This article is over 5 years old, and the information may therefore be outdated. Aducanumab was compared, in a blinded study, to three clinical-stage antibodies using chemical kinetics. The publication describes the use of chemical kinetic analysis to assess the mechanisms of action of four clinical stage anti-Aβ antibodies: aducanumab (Biogen), gantenerumab (Roche), bapineuzumab (Elan) and solane

https://www.multipark.lu.se/article/four-ab-antibodies-only-aducanumab-stems-tide-toxic-oligomers - 2026-05-17

App predicts risk of developing Alzheimer’s

This article is over 5 years old, and the information may therefore be outdated. A new study from Lund University in Sweden shows that validated biomarkers can reveal an individual’s risk of developing Alzheimer’s disease. Using a model that combines the levels of two specific proteins in the blood of those with mild memory impairment, the researchers are able to predict the risk of developing Alz

https://www.multipark.lu.se/article/app-predicts-risk-developing-alzheimers - 2026-05-17

Watch: The cleaning system of the brain captured in 3D footage

This article is over 5 years old, and the information may therefore be outdated. The brain has its own cleaning system that removes harmful substances while we sleep and protects it from diseases such as Alzheimer’s disease. Neuroscientists at Lund University in Sweden have now imaged the cleaning system in 3D, indicating that it is substantially more developed than previously thought. Read the fu

https://www.multipark.lu.se/article/watch-cleaning-system-brain-captured-3d-footage - 2026-05-17

SWEBAGS launched!

This article is over 5 years old, and the information may therefore be outdated. The Swedish Basal Ganglia Society We are happy to announce the formation of SWEBAGS - the Swedish Basal Ganglia Society. SWEBAGS is a nationwide non-profit organization providing a platform for scientific discussion and education in basal ganglia-related research. We aim to foster multidisciplinary collaborations acro

https://www.multipark.lu.se/article/swebags-launched - 2026-05-17

Restoring neural networks and understanding brain disorders

This article is over 5 years old, and the information may therefore be outdated. A research group from Lund Stem Cell Center aims to understand a specific type of neuron that could underlie several brain disorders including schizophrenia, epilepsy and autism, and are developing exciting new strategies to treat them. Read the full article here.

https://www.multipark.lu.se/article/restoring-neural-networks-and-understanding-brain-disorders - 2026-05-17